文献速递MDS 与骨髓增殖性肿瘤贫血与红细胞疾病

骨髓增生异常综合征患者有核红细胞自噬研究

[Study on autophagy in nucleated red blood cells in patients with myelodysplastic syndromes].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2017-01-01

该研究纳入54例MDS患者与33例对照,用透射电镜、流式细胞术、实时PCR和Western blot检测有核红细胞自噬水平。结果发现高危MDS患者有核红细胞LC3B、AMPK、ULK1表达低于对照,mTOR mRNA高于对照,LC3B与HGB正相关,TOM20表达升高。结论为MDS患者有核红细胞自噬受损。

要点

  • 高危MDS患者有核红细胞LC3B表达显著低于对照及低危组。
  • 高危MDS患者AMPK、ULK1 mRNA低于对照,mTOR mRNA高于对照。
  • 高危MDS患者有核红细胞LC3B水平与HGB呈正相关。

核心结论

  • MDS患者有核红细胞自噬受损,高危MDS患者有核红细胞自噬水平下降。

研究设计与样本

  • 研究纳入54例MDS患者为实验组、33例为对照组。
  • 采用透射电镜观察自噬过程,流式细胞术检测GlycoA(+)有核红细胞LC3B,实时PCR检测AMPK、ULK1和mTOR mRNA,Western blot检测TOM20。

主要发现

  • MDS患者有核红细胞中不易观察到自噬体及自噬溶酶体。
  • 高危组MDS患者有核红细胞LC3B表达(0.22±0.12)显著低于对照组(0.43±0.22,P<0.001)及低危组(0.40±0.16,P=0.001)。
  • 高危组MDS患者AMPK表达[0.26(0.60)]显著低于对照组[1.00(2.07),P<0.017]。
  • 高危组MDS患者ULK1 mRNA表达[0.27(3.31)]显著低于对照组[1.07(4.41),P<0.017]。
  • 高危组MDS患者mTOR mRNA表达[1.82(3.74)]显著高于对照组[1.26(1.38),P<0.017]。

关键数值与推荐

  • 高危组MDS患者有核红细胞LC3B水平与HGB呈正相关(r=0.529,P=0.009)。
  • 高危组MDS患者有核红细胞TOM20蛋白表达为9.42±4.42。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the change of autophagy level of bone marrow nucleated red blood cell (RBC) in patients with myelodysplastic syndromes (MDS) . Methods: Fifty-four MDS patients and thirty-three controls were enrolled in this study. The mitophagy were observed by transmission electron microscopy (TEM) . The level of autophagy-associated protein LC3B in GlycoA(+) nucleated RBC was measured by flow cytometry. The expressions of ULK1 and mTOR mRNA in GlycoA(+) nucleated RBC were measured by real-time PCR. The expression of the mitochondrial outer membrane protein TOM20 in GlycoA(+) nucleated RBC was detected by Western blot. Results: Autophagosomes or autolysosomes were scarcely observed by TEM in MDS patients. The expression of LC3B in GlycoA(+) nucleated RBC in high-risk MDS patients (0.22±0.12) was significantly lower than that in normal controls (0.43±0.22, P<0.001) , and lower than that in low-risk MDS patients (0.40±0.16, P=0.001) . The expression of AMPK [0.26 (0.60) ] in GlycoA(+) nucleated RBC in high-risk MDS patients was significantly lower than that in controls [1.00 (2.07) , P<0.017) . The expression of ULK1 mRNA in GlycoA(+) nucleated RBC in high-risk MDS patients [0.27 (3.31) ] was significantly lower than that in controls [1.07 (4.41) , P<0.017]. The level of mTOR mRNA in GlycoA(+) nucleated RBC in high-risk MDS patients [1.82 (3.74) ] was significantly higher than that in controls [1.26 (1.38) , P<0.017]. The level of LC3B in GlycoA(+) nucleated RBC was negatively correlated with the HGB (r=0.529, P=0.009) in high-risk MDS patients. The expression of mitochondrial outer membrane protein TOM20 in high-risk MDS patients was 9.42±4.42. Conclusion: Autophagy is impaired in nucleated RBC of MDS patients. 目的: 研究骨髓增生异常综合征(MDS)患者有核红细胞的自噬水平。 方法: 54例MDS患者为实验组,对照组33例。采用透射电镜观察自噬过程,流式细胞术检测骨髓细胞中GlycoA(+)有核红细胞自噬相关蛋白微管相关蛋白轻链3B(LC3B)的表达水平,Real-time PCR法检测GlycoA(+)有核红细胞自噬相关基因AMPK、ULK1和mTOR mRNA的表达,Western blot法检测GlycoA(+)有核红细胞线粒体外膜蛋白TOM20的表达。 结果: MDS患者有核红细胞中不易观察到自噬体及自噬溶酶体。相对高危组MDS患者有核红细胞LC3B表达(0.22±0.12)显著低于对照组(0.43±0.22,P<0.001)及相对低危组(0.40±0.16,P=0.001)。相对高危组患者AMPK、ULK1 mRNA表达水平明显低于对照组[AMPK:0.26(0.60)对1.00(2.07),ULK1:0.27(3.31)对1.07(4.41),P值均<0.017],mTOR mRNA表达水平明显高于对照组[1.82(3.74)对1.26(1.38),P<0.017]。相对高危组MDS患者有核红细胞LC3B水平与HGB呈正相关(r=0.529,P=0.009)。相对高危组MDS患者有核红细胞TOM20蛋白(9.42±4.42)表达升高。 结论: 高危MDS患者有核红细胞自噬水平下降。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Yang LY, Wang HQ, Fu R, et al. [Study on autophagy in nucleated red blood cells in patients with myelodysplastic syndromes]. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 28565745. doi:10.3760/cma.j.issn.0253-2727.2017.05.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。